Carbocisteine oral preparation and preparation method thereof

By using components such as sodium hydroxide and hydroxypropyl cellulose in carboxymestein preparations to adjust the pH value and form a protective film, combined with microcapsule embedding technology, the insufficient stability and dissolution rate of carboxymestein preparations are solved. Problem, significantly improving its bioavailability and shelf life.

CN118976008APending Publication Date: 2024-11-19JINNUOKANG PHARM TECH (SHIJIAZHUANG) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411065226.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-05
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The current carboxymestetan preparations have poor stability and dissolution speed, resulting in drug susceptibility to loss or contamination during storage, and the active ingredients are not released and absorbed quickly, reducing drug efficacy.

Method used

Sodium hydroxide is used to adjust pH, combine hydroxypropyl cellulose, sodium gluconate and antioxidants to form a protective film, improve solubility and bioavailability, and extend stability and shelf life through carboxymethylstein microcapsule embedding technology .

Benefits of technology

It significantly improves the stability and bioavailability of carboxystamp, extends the shelf life, and ensures the durability and absorption efficiency of the drug.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004979158670000061
    Figure BDA0004979158670000061
  • Figure BDA0004979158670000071
    Figure BDA0004979158670000071
Patent Text Reader

Abstract

The invention relates to the field of carbocisteine preparations, and particularly discloses a carbocisteine oral preparation and a preparation method thereof. The carbocisteine oral preparation is prepared from the following raw materials in parts by weight: 10 to 20 parts of carbocisteine, 8 to 18 parts of sodium hydroxide, 0.3 to 0.5 part of hydroxy propyl cellulose, 0.05 to 0.15 part of sodium gluconate, 0.5 to 1.5 parts of a flavoring agent and 0.03 to 0.05 part of an antioxidant, according to the prepared oral carbocisteine preparation, under the synergistic effect of all the components, the good stability of carbocisteine is kept, and meanwhile the solubility and bioavailability of the oral carbocisteine preparation are improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of carbocysteine ​​preparations, and in particular to a carbocysteine ​​oral preparation and a preparation method thereof. Background Art

[0002] Carbocisteine, also known as carboxymethylcysteine, is a widely used new expectorant and antitussive drug. It acts on the secretion of bronchial glands, increases the secretion of low-viscosity salivary mucin, and reduces the production of high-viscosity fucoxanthin, thereby reducing the viscosity of sputum and making it easier to cough up.

[0003] At present, most carbocysteine ​​preparations on the market are ordinary tablets or capsules. Although their preparation process is simple, the drug's stability and dissolution rate are poor, and it is easy to be lost or contaminated during storage. After patients take the medicine, the active ingredients of the drug cannot be quickly released and absorbed, reducing the efficacy of the drug. Summary of the invention

[0004] In order to improve the water solubility and stability problems of existing carbocysteine ​​preparations, the present application provides a carbocysteine ​​oral preparation and a preparation method thereof.

[0005] In the first aspect, the present application provides a carbocysteine ​​oral preparation, which adopts the following technical solution: A carbocysteine ​​oral preparation comprises the following raw materials in parts by weight: 10-20 parts of carbocysteine, 8-18 parts of sodium hydroxide, 0.3-0.5 parts of hydroxypropyl cellulose, 0.05-0.15 parts of sodium gluconate, 0.5-1.5 parts of flavoring agent and 0.03-0.05 parts of antioxidant.

[0006] By adopting the above technical scheme, sodium hydroxide is used to adjust the pH value of carbocysteine ​​oral preparations, carbocysteine ​​is kept to have good stability, the salt-forming process of carbocysteine ​​is promoted, and the solubility and bioavailability of carbocysteine ​​are improved. Hydroxypropyl cellulose can promote the mutual adhesion of each component in the carbocysteine ​​oral preparation system, which is conducive to the particle forming of the carbocysteine ​​preparation. At the same time, a protective film can be formed on the surface of carbocysteine ​​to slow down the release of active ingredients and improve the bioavailability and storage stability of carbocysteine. Sodium gluconate is alkaline and can adjust the pH value of the drug system. Hydroxypropyl cellulose and sodium gluconate are compounded, while enhancing the adhesion of the carbocysteine ​​system, increasing the solubility of the drug, promoting the uniform dispersion of the drug, and enhancing the bioavailability of the carbocysteine ​​oral preparation. Antioxidants can reduce the oxidation of active ingredients in the carbocysteine ​​oral preparation, extend the stability and shelf life of the carbocysteine ​​oral preparation, and ensure the durability of the efficacy of the drug.

[0007] Preferably, the antioxidant is at least one of sodium sulfite, tocopherol and sodium bisulfite.

[0008] By adopting the above technical scheme, sodium sulfite and sodium bisulfite use their own sulfite ions to inhibit oxidation reactions, effectively prevent the active ingredients in carbocysteine ​​oral preparations from being oxidized, and extend the stability and shelf life of carbocysteine ​​oral preparations. At the same time, sodium sulfite and sodium bisulfite are more stable in aqueous solution compared with other antioxidants, and enhance the water solubility and bioavailability of carbocysteine ​​oral preparations. Tocopherol can effectively scavenge free radicals, protect the fat-soluble components of carbocysteine ​​oral preparations to reduce oxidative damage, and is safe for the human body, with certain nutritional and health benefits. Tocopherol is compounded with sodium sulfite or sodium bisulfite to reduce the generation of oxidation reactions in carbocysteine ​​oral preparations, while maintaining good water solubility and bioavailability.

[0009] Preferably, the flavoring agent comprises an ion exchange resin, a sweetener and a coating agent, and the mass ratio of the ion exchange resin, the sweetener and the coating agent is (3-4):1:(2-3).

[0010] By adopting the above technical solution, the ion exchange resin can adsorb the active components of the drug through adsorption, and in the process of patients taking the drug preparation, the bitterness of the drug can be effectively covered by isolating the contact between the drug and the taste buds. Fruit juice syrup is added to the oral preparation of carbocisteine, which can compete with the bitter taste and combine with the taste receptors, not only correcting the taste but also correcting the odor, and at the same time, it has higher safety and better taste quality, thereby improving the taste of the oral preparation of carbocisteine.

[0011] Preferably, the ion exchange resin has a diameter of 50-100 μm.

[0012] By adopting the above technical solution, by controlling the size of the ion exchange resin within a suitable range, while maintaining an effective flavor-correcting effect, it is possible to avoid the particles being too large, which would cause the patient to have a powdery feeling during the administration process, thereby improving the taste of the oral carbocysteine ​​preparation.

[0013] Preferably, the sweetener is at least one of stevia, fruit juice syrup and saccharin sodium.

[0014] Preferably, the coating agent is one of polyethylene glycol and cellulose acetate titanate.

[0015] By adopting the above technical solution, polyethylene glycol and cellulose acetate titanate form a coating layer on the surface of the active component of the drug, preventing the drug from contacting the taste buds, thereby covering up the bitter taste of the drug. At the same time, polyethylene glycol and cellulose acetate titanate as coating agents can reduce the wear and breakage of the active ingredients of the drug, maintain the structural integrity of the drug, and thus extend the stability and shelf life of the drug.

[0016] Preferably, carbocysteine ​​is prepared into carbocysteine ​​microcapsules in advance, and the capsule materials of the microcapsules are octenyl succinate starch, gelatin and β-cyclodextrin.

[0017] By adopting the above technical scheme, carbocysteine ​​is prepared into carbocysteine ​​microcapsules in advance, which can maintain the stability of carbocysteine ​​nutrients and active substances, and can reduce the oxidation of carbocysteine, thereby improving the stability of carbocysteine ​​oral preparations. Octenyl succinate starch and gelatin can be compounded on the surface of the active component of the drug to form a protective film, wrapping carbocysteine ​​inside, and the cavity structure of β-cyclodextrin can form an inclusion compound with carbocysteine. Through multiple inclusions, carbocysteine ​​is effectively isolated from the external environment, reducing the oxidation of carbocysteine, and improving the chemical stability of carbocysteine ​​and the shelf life of carbocysteine ​​oral preparations. At the same time, carbocysteine ​​is made into carbocysteine ​​microcapsules, which can effectively improve the solubility of carbocysteine ​​oral preparations, adjust the release rate of the drug, achieve a sustained release effect, improve the absorption efficiency of the drug in the gastrointestinal tract, improve bioavailability, reduce the number of administrations, and ensure the effectiveness and safety of the drug.

[0018] Preferably, the preparation method of the carbocysteine ​​microcapsules comprises the following specific steps: mixing gelatin, octenyl succinate starch and β-cyclodextrin, adding water and heating until dissolved, stirring evenly, keeping warm at 45-55°C to form a wall material mixture, grinding and dispersing carbocysteine ​​and adding it to the wall material mixture, dispersing and homogenizing at high speed, and spray drying to obtain carbocysteine ​​microcapsules.

[0019] Preferably, the mass ratio of octenyl succinate starch, gelatin and β-cyclodextrin in the carbocysteine ​​microcapsules is (2-3):(0.5-1):1, and the ratio of carbocysteine ​​to the wall material mixed liquid in the carbocysteine ​​microcapsules is 1:(5-8).

[0020] By adopting the above technical solution and adjusting the appropriate amount of the wall material mixture, the wall material and wall core structure can be made denser, the carbocysteine ​​microcapsules can have a better embedding effect, and the stability of the carbocysteine ​​oral preparation can be improved.

[0021] In a second aspect, the present application provides a method for preparing a carbocysteine ​​oral preparation, which adopts the following technical scheme: a method for preparing a carbocysteine ​​oral preparation, mixing sodium hydroxide and carbocysteine ​​to form a carbocysteine ​​mixed solution, then adding hydroxypropyl cellulose, sodium gluconate, a flavoring agent, and an antioxidant to the carbocysteine ​​mixed solution and mixing them evenly, drying and granulating, and sieving to obtain a carbocysteine ​​oral preparation granule product.

[0022] By adopting the above technical scheme, through the synergistic effect of each component, the prepared carbocysteine ​​oral preparation granule product can have better stability and solubility, improve the shelf life of the active ingredients of the drug, and improve the bioavailability of the carbocysteine ​​oral preparation.

[0023] In summary, this application has the following beneficial effects: 1. Since the present application uses sodium hydroxide to adjust carbocysteine, carbocysteine ​​is kept with good stability. The compounding of hydroxypropyl cellulose and sodium gluconate can enhance the adhesion of each component in the carbocysteine ​​system, increase the solubility of the drug, promote the uniform dispersion of the drug, and enhance the bioavailability of the oral preparation of carbocysteine.

[0024] 2. In the present application, carbocysteine ​​is made into carbocysteine ​​microcapsules, and octenyl succinate starch, gelatin and β-cyclodextrin are used as microcapsule wall materials, which can encapsulate the active components of the drug, improve the stability and solubility of the oral preparation of carbocysteine, and enhance the bioavailability of the oral preparation of carbocysteine. DETAILED DESCRIPTION

[0025] The present application is further described in detail below with reference to the embodiments.

[0026] All raw materials in the examples are commercially available. Example

[0027] Example 1 This embodiment provides a carbocysteine ​​oral preparation, comprising the following raw materials in parts by weight: 15 g of carbocysteine, 13 g of sodium hydroxide, 0.4 g of hydroxypropyl cellulose, 0.1 g of sodium gluconate, 1 g of flavoring agent, and 0.04 g of antioxidant, wherein the antioxidant is sodium sulfite, the flavoring agent is stevia sweetener, and the average molar substitution number of hydroxypropyl cellulose is 0.06.

[0028] The preparation method of a carbocysteine ​​oral preparation comprises the following raw materials in parts by weight: mixing sodium hydroxide, carbocysteine ​​and water, stirring and dissolving, wherein the mass ratio of carbocysteine ​​to water is 1:1, to form a carbocysteine ​​mixed solution; then adding hydroxypropyl cellulose, sodium gluconate, a flavoring agent and an antioxidant into the carbocysteine ​​mixed solution, mixing, stirring evenly, drying and granulating, and passing through a 20-mesh sieve to obtain a carbocysteine ​​oral preparation granule product.

[0029] Example 2 The difference between Example 2 and Example 1 is that the amount of carbocysteine ​​used in the raw materials of the carbocysteine ​​oral preparation is 10g, the amount of sodium hydroxide used is 8g, the amount of hydroxypropyl cellulose used is 0.3g, the amount of sodium gluconate used is 0.15g, the amount of the flavoring agent used is 1.5g, and the amount of the antioxidant used is 0.03g.

[0030] Example 3 The difference between Example 3 and Example 1 is that the amount of carbocysteine ​​used in the raw materials of the carbocysteine ​​oral preparation is 20g, the amount of sodium hydroxide used is 18g, the amount of hydroxypropyl cellulose used is 0.5g, the amount of sodium gluconate used is 0.05g, the amount of the flavoring agent used is 0.5g, and the amount of the antioxidant used is 0.05g.

[0031] Example 4 The difference between Example 4 and Example 1 is that the antioxidant in the raw material of the oral carbocysteine ​​preparation is a mixture of tocopherol and sodium bisulfite, and the mass ratio of tocopherol to sodium bisulfite is 1:1.

[0032] Example 5 The difference between Example 5 and Example 1 is that the flavor correctors in the raw materials of the oral carbocysteine ​​preparation are ion exchange resin and sweetener, and the mass ratio of ion exchange resin to sweetener is 3.5: 1. The ion exchange resin is DuPont Amberlite IRP64 resin, and the diameter of the ion exchange resin is 50-100 μm.

[0033] The preparation method of carbocisteine ​​oral preparation comprises the following specific steps: Sodium hydroxide, carbocysteine, ion exchange resin and water are mixed and stirred to dissolve, the mass ratio of carbocysteine ​​to water is 1:1, and a carbocysteine ​​mixed solution is formed, and then hydroxypropyl cellulose, sodium gluconate, a sweetener and an antioxidant are added to the carbocysteine ​​mixed solution, mixed, stirred evenly, dried and granulated, and passed through a 20-mesh sieve to obtain a carbocysteine ​​oral preparation granule product.

[0034] Example 6 The difference between Example 6 and Example 5 is that the flavor corrector in the raw material of the oral carbocysteine ​​preparation is an ion exchange resin, a sweetener and a coating agent, and the mass ratio of the ion exchange resin, the sweetener and the coating agent is 3.5:1:2.5. The coating agent is polyethylene glycol, and the polyethylene glycol is PEG4000.

[0035] The preparation method of carbocisteine ​​oral preparation comprises the following specific steps: Sodium hydroxide, carbocysteine, ion exchange resin and water are mixed and stirred to dissolve, the mass ratio of carbocysteine ​​to water is 1:1, and a carbocysteine ​​mixed solution is formed, and then hydroxypropyl cellulose, sodium gluconate, a sweetener, a coating agent and an antioxidant are added to the carbocysteine ​​mixed solution, the mixture is dried and granulated, and passed through a 20-mesh sieve to obtain a carbocysteine ​​oral preparation granule product.

[0036] Example 7 The difference between Example 7 and Example 6 is that the coating agent in the raw material of the oral carbocysteine ​​preparation is cellulose acetate titanate.

[0037] Example 8 The difference between Example 8 and Example 6 is that, in the preparation of the oral carbocysteine ​​preparation, carbocysteine ​​is prepared into carbocysteine ​​microcapsules in advance, and the wall material is β-cyclodextrin.

[0038] The preparation method of carbocisteine ​​oral preparation comprises the following raw materials in parts by weight: S1: Mix the wall material with water in a mass ratio of 10:1, heat to 50°C and stir to dissolve to form a wall material mixture, keep warm at 50°C, grind and disperse carbocysteine ​​and add it to the wall material mixture in a ratio of 1:7, disperse at a high speed of 3000r / min for 30min, then homogenize for 5min, and finally spray dry to obtain carbocysteine ​​microcapsules.

[0039] S2: Sodium hydroxide, hydroxypropyl cellulose, sodium gluconate, sweetener, coating agent and antioxidant are dissolved in water, and then mixed with ion exchange resin and carbocysteine ​​microcapsules to form a carbocysteine ​​mixture, which is stirred evenly, dried and granulated, and passed through a 20-mesh sieve to obtain a carbocysteine ​​oral preparation granule product.

[0040] Example 9 The difference between Example 9 and Example 8 is that the wall materials in the raw materials of the oral carbocysteine ​​preparation are octenyl succinate starch and β-cyclodextrin, and the mass ratio of octenyl succinate starch to β-cyclodextrin is 2.5:1.

[0041] The preparation method of carbocisteine ​​oral preparation comprises the following raw materials in parts by weight: S1: Octenyl succinate starch and β-cyclodextrin are mixed to form a wall material, the wall material is mixed with water, the mass ratio of water to wall material is 10:1, the temperature is raised to 50°C and stirred to dissolve to form a wall material mixture, the temperature is kept at 50°C, carbocysteine ​​is ground and dispersed and added to the wall material mixture, the ratio of carbocysteine ​​to the wall material mixture is 1:7, high-speed dispersion is carried out at a speed of 3000r / min for 30min, then homogenized for 5min, and finally spray-dried to obtain carbocysteine ​​microcapsules.

[0042] S2: Sodium hydroxide, hydroxypropyl cellulose, sodium gluconate, sweetener, coating agent and antioxidant are dissolved in water, and then mixed with ion exchange resin and carbocysteine ​​microcapsules to form a carbocysteine ​​mixture, which is stirred evenly, dried and granulated, and passed through a 20-mesh sieve to obtain a carbocysteine ​​oral preparation granule product.

[0043] Example 10 The difference between Example 10 and Example 9 is that the wall materials in the raw materials of the carbocysteine ​​oral preparation are octenyl succinate starch, gelatin and β-cyclodextrin, and the mass ratio of octenyl succinate starch, gelatin and β-cyclodextrin is 2.5::0.8:1.

[0044] The preparation method of carbocisteine ​​oral preparation comprises the following raw materials in parts by weight: S1: Octenyl succinate starch, gelatin and β-cyclodextrin are mixed to form a wall material, the wall material is mixed with water, the mass ratio of water to wall material is 10:1, the temperature is raised to 50°C and stirred to dissolve to form a wall material mixture, the temperature is kept at 50°C, carbocysteine ​​is ground and dispersed and added to the wall material mixture, the ratio of carbocysteine ​​to the wall material mixture is 1:7, high-speed dispersion is carried out at a speed of 3000r / min for 30min, then homogenized for 5min, and finally spray-dried to obtain carbocysteine ​​microcapsules.

[0045] S2: Sodium hydroxide, hydroxypropyl cellulose, sodium gluconate, sweetener, coating agent and antioxidant are dissolved in water, and then mixed with ion exchange resin and carbocysteine ​​microcapsules to form a carbocysteine ​​mixture, which is stirred evenly, dried and granulated, and passed through a 20-mesh sieve to obtain a carbocysteine ​​oral preparation granule product.

[0046] Comparative Example Comparative Example 1 The difference between Comparative Example 1 and Example 1 is that hydroxypropyl cellulose is not used in the raw materials of the oral carbocysteine ​​preparation.

[0047] Comparative Example 2 The difference between Comparative Example 2 and Example 1 is that no antioxidant is used in the raw materials of the oral carbocysteine ​​preparation.

[0048] Performance testing The following performance tests were performed on the carbocisteine ​​oral preparations provided in Examples 1-10 and Comparative Examples 1-2 of the present application. The specific test results are shown in Table 1.

[0049] Detection Methods The carbocysteine ​​oral preparation granules prepared in the present application were mixed with purified water in a ratio of 1:500, and stored in a cool and dry place (temperature not exceeding 20°C, 35%-75% RH) for 0, 6, and 18 months, and under light conditions for 30 days. The carbocysteine ​​oral preparation prepared in the present application was measured by spectrophotometry, and the absorbance was measured at a wavelength of 567nm to measure the carbocysteine ​​content and the appearance of the solution.

[0050] Table 1: Performance test results data table It can be seen from the performance test results that the oral carbocysteine ​​preparation prepared in the present application, under the synergistic effect of various components, maintains good stability of carbocysteine, slows down the release of active ingredients, and improves the bioavailability and storage stability of carbocysteine.

[0051] By comparing Example 4 with Example 1, it can be seen that the comprehensive performance of the carbocysteine ​​oral preparation prepared by Example 4 using a combination of tocopherol and sodium bisulfite as antioxidants is better.

[0052] By comparing Examples 5-6 with Example 1, it can be seen that the coating agent used in Example 6 can improve the taste of the carbocysteine ​​oral preparation in multiple aspects and enhance the mouthfeel of the carbocysteine ​​oral preparation.

[0053] By pre-preparing microcapsules of carbocysteine ​​in Examples 8-10, it can be seen from the performance test results that the stability of the oral preparation of carbocysteine ​​is significantly improved. Through multiple inclusions, carbocysteine ​​is effectively isolated from the external environment, the oxidation of carbocysteine ​​is reduced, and the chemical stability and shelf life of carbocysteine ​​are improved.

[0054] By comparing Comparative Examples 1-2 with Example 1, it can be seen that changing any component of the carbocysteine ​​oral preparation prepared in the present application affects the stability and solubility of the carbocysteine ​​oral preparation. The solubility of the active ingredient of carbocysteine ​​in Comparative Examples 1 and 2 is reduced, and precipitation has occurred, thereby affecting the use of the carbocysteine ​​oral preparation. It further illustrates that the present application increases the solubility of the drug, promotes uniform dispersion of the drug, and maintains good stability of carbocysteine ​​through the synergistic effect of each component.

[0055] This specific embodiment is merely an explanation of the present application and is not a limitation of the present application. After reading this specification, those skilled in the art may make modifications to the present embodiment without any creative contribution as needed, but such modifications are protected by the patent law as long as they are within the scope of the claims of the present application.

Claims

1. A carbocisteine ​​oral preparation, characterized in that: The invention comprises the following raw materials in parts by weight: 10-20 parts of carbocysteine, 8-18 parts of sodium hydroxide, 0.3-0.5 parts of hydroxypropyl cellulose, 0.05-0.15 parts of sodium gluconate, 0.5-1.5 parts of flavoring agent and 0.03-0.05 parts of antioxidant.

2. The carbocisteine ​​oral preparation according to claim 1, characterized in that The antioxidant is at least one of sodium sulfite, tocopherol and sodium bisulfite.

3. The carbocisteine ​​oral preparation according to claim 1, characterized in that The flavoring agent comprises an ion exchange resin, a sweetener and a coating agent, wherein the mass ratio of the ion exchange resin, the sweetener and the coating agent is (3-4):1:(2-3).

4. The carbocisteine ​​oral preparation according to claim 3, characterized in that The ion exchange resin has a diameter of 50-100 μm.

5. The carbocisteine ​​oral preparation according to claim 3, characterized in that The sweetener is at least one of stevia, fruit juice syrup and saccharin sodium.

6. The oral carbocysteine ​​preparation according to claim 3, characterized in that The coating agent is one of polyethylene glycol and cellulose acetate titanate.

7. The carbocisteine ​​oral preparation according to claim 1, characterized in that Carbocysteine ​​is prepared into carbocysteine ​​microcapsules in advance, and the capsule materials of the microcapsules are octenyl succinate-esterified starch, gelatin and beta-cyclodextrin.

8. The carbocisteine ​​oral preparation according to claim 7, characterized in that The preparation method of the carbocysteine ​​microcapsules comprises the following specific steps: mixing gelatin, octenyl succinate starch and beta-cyclodextrin, adding water and heating until dissolved, stirring evenly, keeping warm at 45-55° C. to form a wall material mixed liquid, grinding and dispersing carbocysteine ​​and adding it to the wall material mixed liquid, dispersing and homogenizing at high speed, and spray drying to obtain the carbocysteine ​​microcapsules.

9. The carbocisteine ​​oral preparation according to claim 8, characterized in that The mass ratio of octenyl succinate starch, gelatin and beta-cyclodextrin in the carbocysteine ​​microcapsules is (2-3): (0.5-1): 1, and the ratio of carbocysteine ​​to the wall material mixed liquid in the carbocysteine ​​microcapsules is 1: (5-8).

10. A method for preparing the oral carbocysteine ​​preparation according to any one of claims 1 to 9, characterized in that: The method comprises the following specific steps: mixing and dissolving sodium hydroxide and carbocysteine ​​to form a carbocysteine ​​mixed solution, then adding hydroxypropyl cellulose, sodium gluconate, a flavoring agent and an antioxidant into the carbocysteine ​​mixed solution and mixing the mixture evenly, drying and granulating the mixture, and sieving the mixture to obtain a carbocysteine ​​oral preparation granule product.